Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 12 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 12043843

    Materials and methods for treatment of hemoglobinopathies

    Vertex Pharmaceuticals Incorporated · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  2. US 12042529

    Optimization of enzyme replacement therapy for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  3. US 12043601

    N-substituted-1H-1,2,4-triazole-3-carboxamides, analogues thereof, and methods of treatment using same

    The Regents of the University of Colorado · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  4. US 12037363

    Peptides for Covid-19 prevention and treatment

    SOTIRA COVID, LLC · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  5. US 12036278

    Smallpox vaccine for cancer treatment

    Calidi Biotherapeutics (Nevada), Inc. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  6. US 12036255

    Bacteriophage compositions and methods for treatment of bacterial infections

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  7. US 12030940

    Immunotherapeutic tumor treatment method

    Nektar Therapeutics · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  8. US 12031136

    Treatment for skeletal diseases caused by intracellular protein trafficking defects

    The Board of Regents of the University of Oklahoma · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  9. US 12029732

    Treatment of vascular and lymphatic disease

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  10. US 12031132

    Systems and methods for the treatment of hemoglobinopathies

    Editas Medicine, Inc. · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  11. US 12029755

    Carbon monoxide-based therapies and implantable devices for the treatment of vascular disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  12. US 12030869

    5-membered heteroaryl carboxamide compounds for treatment of HBV

    ASSEMBLY BIOSCIENCES, INC. · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  13. US 12029794

    Virus-like particle conjugates for diagnosis and treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Serv · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  14. US 12023348

    EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Jul 2, 2024 · Expires Jun 27, 2044

    granted
  15. US 12023388

    Detection and treatment of caries and microcavities with nanoparticles

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 2, 2024 · Expires Jun 27, 2044

    granted
  16. US 12018259

    Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  17. US 12018074

    Anti CCL24 (eotaxin2) antibodies for use in the treatment of hepatic diseases

    CHEMOMAB LTD. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  18. US 12016948

    Micromotors and nanomotors for gastrointestinal diagnosis and treatment applications

    The Regents of the University of California · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  19. US 12016904

    Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF

    Takeda Pharmaceutical Company Limited · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  20. US 12012597

    Cancer treatment using siRNA to modulate expression of PRDM2/RIZ protein

    ARIZ Precision Medicine, Inc. · Granted Jun 18, 2024 · Expires Jun 13, 2044

    granted
  21. US 12006340

    Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

    Atea Pharmaceuticals, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  22. US 12004819

    System and method of performing treatment along a lumen network

    Covidien LP · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  23. US 2024180883

    TREATMENT OF MIGRAINE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Jun 6, 2024 · Expires Jun 1, 2044

    granted
  24. US 11998529

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted